Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06754514 · ClinicalTrials.gov registry record
Organ Retractor Device Study
A clinical trial of Liver Retraction During Bariatric Surgery, sponsored by Boehringer Labs.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06754514 is a study of Liver Retraction During Bariatric Surgery that is actively recruiting participants, run by Boehringer Labs. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06754514, a study of Liver Retraction During Bariatric Surgery, is actively recruiting participants, sponsored by Boehringer Labs.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.
Conditions Studied
Interventions
- DEVICE liver retraction
Study Locations (1)
North Carolina
- WakeMed Health & Hospitals - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-03-14 |
| Est. Completion | 2025-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06754514
The ClinicalTrials.gov registry entry for NCT06754514 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boehringer Labs, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Retraction During Bariatric Surgery appearing as the primary indexed condition, and to 1 intervention - of which liver retraction is the first listed.
NCT06754514 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06754514 about?
NCT06754514 is a clinical study titled "Organ Retractor Device Study". This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing primary robotic bariatric surgery.
What is the current status of trial NCT06754514?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-03-14. Estimated completion is 2025-01.
What conditions does trial NCT06754514 study?
This clinical trial studies the following conditions: Liver Retraction During Bariatric Surgery.
What interventions are being tested in trial NCT06754514?
The interventions under investigation include: liver retraction (DEVICE).
Who is sponsoring clinical trial NCT06754514?
This trial is sponsored by Boehringer Labs, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06754514 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.